$PDS Biotechnology (PDSB.US)$ NEWS PDS Biotechnology Announc...
NEWS
PDS Biotechnology Announces Details of Virtual KOL Event
PDS Biotechnology announced details of a virtual Key Opinion Leader (KOL) event focusing on updated Phase 2 trial results and unmet needs in advanced head and neck cancer. The event will discuss the positive data from the VERSATILE-002 trial and plans for a triple combination trial. Panel participants include renowned experts in the field.
Positive data from the VERSATILE-002 Phase 2 clinical trial
Focus on unmet needs in HPV-positive head and neck cancer
Renowned experts participating in the event
Focus on unmet needs in HPV-positive head and neck cancer
Renowned experts participating in the event
Disclaimer: Community is offered by Moomoo Technologies Inc. and is for educational purposes only.
Read more
Comment
Sign in to post a comment
Spread kindness and love. Life is short. Don’t let greed eat you.
737Followers
75Following
4732Visitors
Follow